Evolution of mouse hepatitis virus: Detection and characterization of spike deletion variants during persistent infection

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2959-2969

  Rowe, Cynthia L ^a   Baker, Susan C ^a   Nathan, Meera J ^b   Fleming, John O ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CHRONIC DISEASE; CORONAVIRUS; DNA SEQUENCE; GENE DELETION; HEPATITIS VIRUS; HYBRIDIZATION; INFECTION RISK; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0030941096     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2959-2969.1997     Document Type: Article

References (57)

1. Adami, C., J. Pooley, J. Glomb, E. Stecker, F. Fazal, J. O. Fleming, and S. C. Baker. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Banner, L. R., J. G. Keck, and M. M. C. Lai. 1990. A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175:548-555.
3. Banner, L. R., and M. M. C. Lai. 1991. Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology 185:441-445.
4. Bergmann, C. C., Q. Yao, M. Lin, and S. A. Stohlman. 1996. The JHM strain of mouse hepatitis virus induces a spike protein-specific D-b-restricted cytotoxic T cell response. J. Gen. Virol. 77:315-325.
5. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor are antagonists for antiviral cytotoxic T cells. Nature 369: 407-410.
6. Cascone, P. J., T. F. Haydar, and A. E. Simon. 1993. Sequences and structures required for recombination between virus-associated RNAs. Science 260:801-805.
7. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127-8131.
8. Chang, S. Y., A. Shin, and S. Kwok. 1993. Detection of variability in natural populations of viruses by polymerase chain reaction. Methods Enzymol. 224:428-432.
9. Collins, A. R., R. L. Knobler, H. Powell, and M. J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell fusion. Virology 119:358-371.
10. Couillin, I., B. Culmana-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129-1134.
11. Dales, S., and R. Anderson. 1995. Pathogenesis and diseases of the central nervous system caused by murine coronaviruses, p. 257-384. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, N.Y.
12. Dalziel, R. G., P. W. Lampert, P. J. Talbot, and M. J. Buchmeier. 1986. Site specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:463-471.
13. Domingo, E., C. Escarmis, M. A. Martinex, E. Martinez-Salas, and M. G. Mateau. 1992. Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 176:33-47.
14. Duarte, E. A., I. S. Novella, S. C. Weaver, E. Domingo, S. Wain-Hobson, D. K. Clarke, A. Moya, S. F. Elena, J. C. de la Torre, and J. J. Holland. 1994. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3:201-214.
15. Eigen, M. 1993. The origin of genetic information: viruses as models. Gene 135:37-17.
16. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187:178-188.
17. Fazakerley, J. K., and M. J. Buchmeier. 1993. Pathogenesis of virus-induced demyelination. Adv. Virus Res. 42:249-324.
18. Fleming, J. O., M. D. Trousdale, F. A. K. El-Zaatari, and S. A. Stohlman. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:869-875.
19. Fleming, J. O., M. D. Trousdale, J. Bradbury, S. A. Stohlman, and L. P. Weiner. 1987. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb. Pathog. 3:9-20.
20. Fleming, J. O., and L. B. Pen. 1988. Measurement of the concentration of murine IgG monoclonal antibody in hybridoma supernatants and ascites in absolute units by sensitive and reliable enzyme-linked immunosorbent assay (ELISA). J. Immunol. Methods 110:8-11.
21. Fleming, J. O., F. I. Wang, M. D. Trousdale, D. R. Hinton, and S. A. Stohlman. 1993. Interaction of immune and central nervous systems: Contribution of antiviral Thy-1+ cells to demelination induced by coronavirus JHM. Reg. Immunol. 5:37-43.
22. Fleming, J. O., C. Adami, J. Pooley, J. Glomb, E. Stecker, F. Fazal, and S. C. Baker. 1995. Mutations associated with viral sequences isolated from mice persistently infected with MHV-JHM. Adv. Exp. Med. Biol. 380:591-595.
23. Gallagher, T. M., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 64:731-741.
24. Holland, J. J. 1993. Replication error, quasispecies populations and extreme evolution rates of RNA viruses, p. 203-218. In S. S. Morse (ed.), Emerging viruses. Oxford University Press, Oxford, United Kingdom.
25. Holmes, K. V., and M. M. C. Lai. 1996. Coronaviridae: the viruses and their replication, p. 1075-1093. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
26. Jackson, D. P., D. H. Percy, and V. L. Morris. 1984. Characterization of murine hepatitis virus (JHM) RNA from rats with experimental encephalomyelitis. Virology 137:297-304.
27. Jarvis, T. C., and K. Kirkegaard. 1992. Poliovirus RNA recombination: mechanistic studies in absence of selection. EMBO J. 11:3135-3145.
28. Keck, J. G., G. K. Matsushima, S. Makino, J. O. Fleming, D. M. Vannier, S. A. Stohlman, and M. M. C. Lai. 1988. In vivo RNA-RNA recombination of coronavirus in mouse brain. J. Virol. 62:1810-1813.
29. Kirkegaard, K., and D. Baltimore. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433-443.
30. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369:403-407.
31. Kodama, T., K. Mori, T. Kawahara, D. J. Ringler, and R. C. Desrosiers. 1993. Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS. J. Virol. 67:6522-6534.
32. Kyuwa, S., and S. A. Stohlman. 1990. Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Semin. Virol. 1:273-280.
33. Lai, M. M. C. 1992. RNA recombination in animal and plant viruses. Microbioi. Rev. 56:61-79.
34. La Monica, N., L. R. Banner, V. L. Morris, and M. M. C. Lai. 1991. Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology 182:883-888.
35. Lavi, E., D. H. Gilden, M. K. Highkin, and S. R. Weiss. 1986. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab. Anim. Sci. 36:130-135.
36. Li, Y., and L. A. Ball. 1993. Nonhomologous RNA recombination during negative-strand synthesis of flock house virus RNA. J. Virol. 67:3854-3860.
37. Luytjes, W., L. S. Sturman, P. J. Bredenbeek, J. Charite, B. A. M. van der Zeust, M. C. Horzinek, and W. J. M. Spaan. 1987. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology 161:479-487.
38. Makino, S., F. Taguchi, M. Hayami, and K. Fujiwara. 1983. Characterization of small plaque mutants of mouse hepatitis virus, JHM strain. Microbiol. Immunol. 27:445-454.
39. Makino, S., J. G. Keck, S. A. Stohlman, and M. M. C. Lai. 1986. High-frequency RNA recombination of murine coronaviruses. J. Virol. 57:729-737.
40. Martell, M., J. I. Esteban, J. Quer, J. Genesca, A. Weiner, R. Esteban, J. Guardia, and J. Gomez. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66:3225-3229.
41. Morris, V. L., C. Tieszer, J. Mackinnon, and D. Percy. 1989. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169:127-136.
42. Moskophidis, D., and R. M. Zinkernagel. 1995. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69: 2187-2193.
43. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. V. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611.
44. Parker, S., T. M. Gallagher, and M. J. Buchmeier. 1989. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173: 664-673.
45. Pewe, L., G. F. Wu, E. M. Barnett, R. F. Castro, and S. Perlman. 1996. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 5:253-262.
46. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
47. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
48. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
49. Schmidt, I., M. Skinner, and S. Siddell. 1987. Nucleotide sequence of the gene encoding the surface projection glycoprotein of coronavirus MHV-JHM. J. Gen. Virol. 68:47-56.
50. Siddell, S. G. 1995. The coronaviridae: an introduction, p. 1-9. In S. G. Siddell (ed.). The Coronaviridae. Plenum Press, New York, N.Y.
51. Stohlman, S. A., and L. P. Weiner. 1981. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31:38-44.
52. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activitv of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
53. Taguchi, F., T. Ikeda, and H. Shida. 1992. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73:1065-1072.
54. Taguchi, F., H. Kubo, H. Takahasni, and H. Suzuki. 1995. Localization of neurovirulence determinant for rats on the Sl subunit of murine coronavirus JHMV. Virology 208:67-74.
55. Wang, F.-I., J. O. Fleming, and M. M. C. Lai. 1992. Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity. Virology 186:742-749.
56. Wege, H., M. Koga, R. Watanabe, K. Nagashima, and V. ter Meulen. 1983. Neurovirulence of murine coronavirus JHM temperature-sensitive mutants in rats. Infect. Immun. 39:1316-1324.
57. Wege, H., J. Winter, and R. Meyermann. 1988. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J. Gen. Virol. 69:87-98.